Omkar Pharmachem Intrinsic Value
OMKARPH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹8.92 | ₹7.14 - ₹10.70 | -70.0% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹9.00 | ₹8.10 - ₹9.90 | -69.7% | Book Value/Share: ₹9.00, P/B: 1.0x |
| PEG Ratio Method | growth | ₹8.92 | ₹8.03 - ₹9.81 | -70.0% | EPS Growth: 2.7%, Fair P/E: 2.1x |
| Growth Adjusted P/E | growth | ₹8.92 | ₹8.03 - ₹9.81 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹8.92 | ₹8.03 - ₹9.81 | -70.0% | EPS: ₹0.20, BVPS: ₹9.00 |
Want to compare with current market value? Check OMKARPH share price latest .
Valuation Comparison Chart
OMKARPH Intrinsic Value Analysis
What is the intrinsic value of OMKARPH?
Based on our comprehensive analysis using 5 different valuation methods, the estimated intrinsic value of Omkar Pharmachem (OMKARPH) is ₹8.92 (median value). With the current market price of ₹29.74, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹8.92 to ₹9.00, indicating ₹8.92 - ₹9.00.
Is OMKARPH undervalued or overvalued?
Based on our multi-method analysis, Omkar Pharmachem (OMKARPH) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.11 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
Related Pages for Omkar Pharmachem
Additional stock information and data for OMKARPH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |